ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

DRUG BetaShares Capital Limited

8.72
-0.02 (-0.23%)
Last Updated: 20:38:50
Delayed by 20 minutes

BetaShares Capital Financial Summary

The current DRUG market cap is 1.38B. The company's latest EPS is AUD 0.0442 and P/E is 197.51.

Year End June 29 2023 20192020202120222023
AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)
Total Revenue 2.9M3.92M15.62M2.46M7.94M
Operating Income 00000
Net Income 2.7M3.66M15.13M1.57M6.99M
Year End June 29 2023 20192020202120222023
AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)
Total Assets 31.08M49.56M115.11M165.11M161.45M
Total Liabilities 15k1.52M7.35M6.3M3.22M
Total Equity 31.07M48.04M107.76M158.81M158.23M

Cash Flow

Year End June 29 2023 20192020202120222023
AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)
Operating -3.79M-12.34M-50.55M-44.16M7.28M
Investing N/A N/A N/A N/A N/A
Financing 3.77M12.34M50.67M44.38M-7.57M
Market Cap 1.38B
Price to Earnings Ratio 197.51
Price to Sales Ratio 173.9
Price to Cash Ratio 12.47k
Price to Book Ratio 8.73
Dividend Yield -

Share Statistics

Shares Outstanding 158.23M
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change -
52 Week High -
52 Week Low -
Spread (Intraday) 0.01 (0.11%)

Company Info

Company Name BetaShares Capital Limited
Address level 11
sydney, new south wales 2000
Website https://www.betashares.com.au
Industry finance services (6199)

Your Recent History

Delayed Upgrade Clock